Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis of Results from Phase 2/3 Studies

  • William J. Sandborn
  • , Brian G. Feagan
  • , Silvio Danese
  • , Christopher D. O'Brien
  • , Elyssa Ott
  • , Colleen Marano
  • , Thomas Baker
  • , Yiying Zhou
  • , Sheri Volger
  • , Ilia Tikhonov
  • , Christopher Gasink
  • , Bruce E. Sands
  • , Subrata Ghosh

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis of Results from Phase 2/3 Studies'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science